stella
beta
Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma — Stella
Recruiting
Back to Oral Squamous Cell Carcinoma trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(3 sites)
China
Peking university Shenzhen hospital, Shenzhen, Guangdong
Hospital of Stomatology, Wuhan University, Wuhan, Hubei
Xiangya Hospital of Central South University, Changsha, Hunan
View full record on ClinicalTrials.gov